CTOs on the Move

Modulim

www.modulim.com

 
Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, improve outcomes and reduce costs across the continuum ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.modulim.com
  • 2400 Barranca Parkway Suite 2B
    Irvine, CA USA 92606
  • Phone: 949.825.5080

Executives

Name Title Contact Details

Similar Companies

Intrinsic Therapuetics

Intrinsic Therapuetics is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ImaSight Inc

ImaSight Inc is a Gatineau, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KOTYS

KOTYS is a Powell, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corindus

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."

Chesapeake

Chesapeake is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.